Experience with ceftaroline fosamila in the treatment of community-acquired pneumonia

Analysed the effectiveness and safety of ceftaroline in the treatment of community-acquired pneumonia in a pulmonology department of the hospital. Its use has shown the high efficiency of therapy and a good safety profile. Against the backdrop of the potential growth of antibiotic resistance of microorganisms to antibiotics commonly used in the hospital, the appearance in the arsenal of medical practitioners a new effective drug - ceftaroline fosamila - opens an important perspective in the treatment of community-acquired pneumonia.

community-acquired pneumonia, pulmonary conditions therapy department, the use of ceftaroline fosamila